Soporifics giant GlaxoSmithKline plans to sell its UK Horlicks business and close the location
The closure of the plant in Slough, Berkshire, as well as the proposed outsourcing of some construction at its site in Worthing, West Sussex, will lead to the loss of 320 undying jobs over the next four years.
Glaxo has also unhesitating not to go ahead with a planned £350million investment to build a biopharmaceutical system in Ulverston, Cumbria, which would have created hundreds of assignments.
It is weighing a potential sale of its cephalosporins antibiotics business including turn out facilities.
These medicaments are produced in Ulverston, at part of its Barnard Castle site in County Durham and in Verona, Italy.
Once again the next three years it plans to invest more than £140million at localities in Ware, Hertfordshire, Barnard Castle and Montrose, Scotland, to expand put together of its respiratory and